MarketBeat | Real-Time Financial News and Analysis

Open Main Menu Open Sidebar

Oramed Pharmaceuticals Company Profile (NASDAQ:ORMP)

Consensus Ratings for Oramed Pharmaceuticals (NASDAQ:ORMP) (?)
Ratings Breakdown: 1 Buy Rating(s)
Consensus Rating:Buy (Score: 3.00)
Consensus Price Target: $30.00 (355.24% upside)

Analysts' Ratings History for Oramed Pharmaceuticals (NASDAQ:ORMP)
Show:
DateFirmActionRatingPrice TargetActions
7/8/2015MLV & Co.Reiterated RatingBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/30/2015MLV & Co.Reiterated RatingBuy$30.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/18/2015MLV & Co.Set Price TargetBuy$30.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
4/13/2015MLV & Co.Initiated CoverageBuy$27.00 -> $30.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
7/1/2014AegisReiterated RatingBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
1/30/2014AegisBoost Price TargetBuy$30.00 -> $35.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
1/8/2014AegisBoost Price TargetBuy$25.00 -> $30.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
1/7/2014MLV & Co.Initiated CoverageBuy$27.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
12/3/2013Capital Ideas ResearchInitiated CoverageBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
12/3/2013AegisInitiated CoverageBuy$25.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
(Data available from 8/1/2013 forward)
            As Featured by CNBC As Featured by The Wall Street Journal As Featured by MarketWatch As Featured by The Boston Globe As Featured by StockTwits As Featured by Seeking Alpha